Hadasit Bio (Israel) Financial Diagnostics

HDST -- Israel Stock  

ILS 460.20  0.20  0.0435%

Hadasit Bio price decrease over the last few months may raise some interest from investors. The Stock closed today at a share price of 460.0 on 490.000 in trading volume. The company management were not very successful in positioning the corporation components to exploit market volatility in April. However, diversifying your holdings with Hadasit Bio Holdings or similar stocks can still protect your portfolio during high-volatility market scenarios. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 1.4521. The below-average Stock volatility is a good sign for a longer term investment options and for buy-and-hold investors. This diagnostics interface makes it easy to digest most current publicly released information about Hadasit Bio as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Hadasit Bio price relationship with some important fundamental indicators such as market cap and management efficiency. Please also check Risk vs Return Analysis.

Hadasit Bio Note

The company recorded loss per share of 0.03. Hadasit Bio Holdings last dividend was issued on 2019-02-07. The entity had 1:5 split on 2016-07-24. Hadasit Bio-Holdings, Ltd operates in the biotechnology industry in Israel. The company was founded in 2005 and is based in Jerusalem, Israel. Hadasit Bio is traded on Tel Aviv Stock Exchange in Israel. To learn more about HADASIT BIO HLDGS call Michel Habib at 972 2 677 8757 or check out http://www.hbl.co.il.

Hadasit Bio Holdings Alerts

Hadasit Bio Holdings is not yet fully synchronised with the market data
Hadasit Bio Holdings generates negative expected return over the last 30 days
Hadasit Bio Holdings has high likelihood to experience some financial distress in the next 2 years
HADASIT BIO HLDGS has accumulated about 18.14M in cash with (16.46M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.64.

Market Capitalization

The company currently falls under 'Micro-Cap' category with current market capitalization of 52.04M.


The company has Profit Margin (PM) of (126.4) % which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average.

Management Efficiency

Hadasit Bio Holdings has return on total asset (ROA) of (3.66) % which means that it has lost $3.66 on every $100 spent on asset. This is way below average. Similarly, it shows return on equity (ROE) of (8.9) % meaning that it generated substantial loss on money invested by shareholders.

Hadasit Bio Technical and Predictive Indicators

Did you try this?

Run Balance Of Power Now


Balance Of Power

Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
All  Next Launch Module
Please also check Risk vs Return Analysis. Please also try Focused Opportunities module to build portfolios using our predefined set of ideas and optimize them against your investing preferences.
Search macroaxis.com